The SCF ubiquitin ligase: Insights into a molecular machine

Nature Reviews Molecular Cell Biology

Volumn 5, Issue 9, 2004, Pages 739-751

  Cardozo, Timothy ^a   Pagano, Michele ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CUL1 PROTEIN; F BOX PROTEIN; PROTEIN; SCF PROTEIN; SKP1 PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL METABOLISM; CRYSTAL STRUCTURE; ENZYME SPECIFICITY; ENZYME STRUCTURE; F BOX DOMAIN; MACHINE; MAMMAL; MITOSIS; MOLECULAR BIOLOGY; MOLECULAR MACHINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW;

ANIMALS; CELL CYCLE; CYCLIN-DEPENDENT KINASES; DRUG DESIGN; EVOLUTION, MOLECULAR; F-BOX PROTEINS; HUMANS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; SKP CULLIN F-BOX PROTEIN LIGASES;

MAMMALIA;

EID: 4444318673     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1471     Document Type: Review

References (128)

1. Guardavaccaro, D. & Pagano, M. Oncogenic aberrations of cullin-dependent ubiquitin ligases. Oncogene 23, 2037-2049(2004).
2. Kraus. B, et al. A novel cyclin gene (CCNF) in the region of the polycysti kidney disease gene (PKD1). Genomics 24, 27-33 (1994).
3. Murray, A. W. Recycling the cell cycle: cyclins revisited. Cell 116, 221-234 (2004).
4. Bai, C., Richman, R. & Elledge, S. J. Human cyclin F. EMBO J. 13, 6087-6098 (1994).
5. Bai, C. et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263-274 (1996). Seminal paper that identified and assigned a function to the F-box domain.
6. Feldman, R. M., Correll, C. C., Kaplan, K. B. & Deshaies, R. J. A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 91, 221-230 (1997). References 6 and 7 were the first studies to put the data together to identify the SCF ubiquitin ligase as a functional entity.
7. Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J. & Harper, J. W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91, 209-219 (1997).
8. Cenciarelli, C. et al. Identification of a family of human F-box proteins. Curr. Biol. 9, 1177-1179 (1999).
9. Winston, J. T., Koepp, D. M., Zhu, C., Elledge, S. J. & Harper, J. W. A family of mammalian F-box proteins. Curr. Biol. 9, 1180-1182 (1999).
10. Smith, T. F., Gatatzes, C., Saxena, K. & Neer, E. J. The WD repeat: a common architecture for diverse functions. Trends Biochem. Sci. 24, 181-185 (1999).
11. Kobe, B. & Kajava, A. V. The leucine-rich repeat as a protein recognition motif. Curr. 0pin. Struct. Biol. 11, 725-732 (2001).
12. Enkhbayar, R, Kamiya, M., Osaki, M., Matsumoto, T. & Matsushima, N. Structural principles of leucine-rich repeat (LRR) proteins. Proteins 54, 394-403 (2004).
13. Yoshida, Y. et al. E3 ubiquitin ligase that recognizes sugar chains. Nature 418, 438-442 (2002).
14. Yoshida, Y. et al. Fbs2 is a new member of the E3 ubiquitin ligase family that recognizes sugar chains. J. Biol. Chem. 278, 43877-43884 (2003).
15. Cdh1. Nature Cell Biol. 4, 358-366 (2002).
16. Reimann, J. D. et al. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 105, 645-855 (2001).
17. Kawakami, K. et al. Proviral insertions in the zebrafish hagoromo gene, encoding an F-box/WD40-repeat protein, cause stripe pattern anomalies. Curr. Biol. 10, 463-466 (2000).
18. Sidow, A. et al. A novel member of the F-box/WD40 gene family, encoding dactylin, is disrupted in the mouse dactytaplasia mutant. Nature Genet 23, 104-107 (1999).
19. Basel, D., DePaepe, A., Kilpatrick, M. W. & Tsipouras, P. Spilt hand foot malformation is associated with a reduced level of Dactylin gene expression. Clin. Genet. 64, 350-354 (2003).
20. Ianakiev, P. et al. Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am. J. Hum. Genet. 67, 59-66 (2000).
21. Dias, D. C., Dolios, G., Wang, R. & Pan, Z. Q. CUL7: A DOC domain-containing cullin selectively binds Skp1-Fbx29 to form an SCF-like complex. Proc. Natl Acad. Sci. USA 99, 16601-16606 (2002).
22. Arai, T. et al. Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesis. Proc. Natl Acad. Sci. USA 100, 9855-9860 (2003).
23. Masuda, K. et al. Molecular profile of synovial fibroblasts in rheumatoid arthritis depends on the stage of proliferation. Arthritis Res. 4, R8 (2002).
24. den Engelsman, J., Keijsers, V., de Jong, W. W. & Boelens, W. C. The small heat-shock protein αB-crystallin promotes FBX4-dependent ubiquitination. J. Biol. Chem. 278, 4699-4704 (2003).
25. Sandri, M. et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399-412 (2004).
26. Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A. & Goldberg, A. L. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl Acad. Sci. USA 98, 14440-14445 (2001).
27. Bodine, S. C. et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708 (2001).
28. Musacchio, A. & Hardwick, K. G. The spindle checkpoint: structural insights into dynamic signalling. Nature Rev. Mol. Cell Biol. 3, 731-741 (2002).
29. Zachariae, W. & Nasmyth, K. Whose end is destruction: cell division and the anaphase-promoting complex. Genes Dev. 13, 2039-2058 (1999).
30. Peters, J. M. The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol. Cell 9, 931-943 (2002).
31. Qu, Z., MacLellan, W. R. & Weiss, J. N. Dynamics of the cell cycle: checkpoints, sizers, and timers. Biophys. J. 85, 3600-3611 (2003).
32. -/- phenotype is rescued by p27 deficiency. It also shows that p27 inhibits Cdk1 as well as Cdk2.
33. Sherr, C. J. & Roberts, J. M. CDK inhibtors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512 (1999).
34. Amati, B. & Vlach, J. Kip1 meets SKP2: new links in cell-cycle control. Nature Cell Biol. 1, E91-E93 (1999).
35. Carrano, A. C., Eytan, E., Hershko, A. & Pagano, M. Skp2 is required for the ubiquitin-mediated degradation of the Cdk-inhibitor p27. Nature Cell Biol. 1, 193-199 (1999).
36. Kip1, potyploidy and centrosomeoverduplication. EMBO J. 19, 2069-2081 (2000).
37. Skp2 complex through phosphorylated Thr187 in p27. Curr. Biol. 9, 661-664 (1999).
38. Kip1 degradation and induces S phase in quiescent cells. Nature Cell Biol. 1, 207-214 (1999).
39. CIP1/WAF1 and cyclin D proteins. Proc. Natl Acad. Sci. USA 95, 11324-11329 (1998).
40. Cip1 in S phase. J. Biol. Chem. 278, 25752-25757 (2003).
41. Cch1 ubiquitin ligase. Nature 428, 190-193 (2004). References 41 and 42 established the biological 'handshake' between the main cell-cycle ubiquitin ligases.
42. Wei, W. et al. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428, 194-198 (2004).
43. Donzeili, M. et al. Dual mode of degradation of Cdc25 A phosphatase. EMBO J. 21, 4875-4884 (2002).
44. Wirth, K. G. et al. Loss of the anaphase-promoting complex in quiescent cells causes unscheduled hepatocyte proliferation. Genes Dev. 18, 88-98 (2004). Describes and confirms the phenotype of APC/C disruption.
45. Reimann, J. D., Gardner, B. E., Margottin-Goguet, F. & Jackson, P. K. Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins. Genes Dev. 15, 3278-3285 (2001).
46. Busino, L. et al. Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage. Nature 426, 87-91 (2003).
47. Jin, J. et al. SCFβ-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17, 3062-3074 (2003).
48. Fbw7 ubiquitin ligase. Science 294, 173-177 (2001).
49. Moberg, K. H., Bell, D. W., Wahrer, D. C., Haber, D. A. & Hariharan, I. K. Archipelago regulates cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 413, 311-316 (2001).
50. Strohmaier, H. et al. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413, 316-322 (2001).
51. β-TCP. Proc. Natl Acad. Sci. USA 101, 4419-4424 (2004).
52. Ayad, N. G. et al. Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC. Cell 113, 101-113 (2003).
53. Guardavaccaro, D. et al. Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo. Dev. Cell 4, 799-812 (2003).
54. βTrCP/Slimb ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4, 813-826 (2003).
55. Reed, S. I. Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nature Rev. Mol. Cell Biol. 4, 855-864 (2003).
56. Kip1. Genes Dev. 11, 1464-1478 (1997).
57. Montagnoli, A. et al. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13, 1181-1189 (1999).
58. Kip1. EMBO J. 16, 5334-5344 (1997).
59. Welcker, M. et al. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol. Cell 12, 381-392 (2003).
60. Moshe, Y., Boulaire, J., Pagano, M. & Hershko, A. Role of Polo-like kinase in the degradation of Emi1, a regulator of the anaphase promoting complex/cyclosome. Proc. Natl Acad. Sci. USA 101, 7937-7942 (2004).
61. Cope, G. A. & Deshaies, R. J. COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases. Cell 114, 663-671 (2003).
62. Hon, W. C. et al. Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL. Nature 417, 975-978 (2002).
63. Min, J. H. et al. Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886-1889 (2002).
64. Schulman, B. et al. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature, 408, 381-386(2000). The only crystallographic study so far on the substrate-binding portion of an FBL protein.
65. Stebbins, C. E., Kaelin, W. G. Jr. & Pavletich, N. P. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284, 455-461 (1999).
66. β-TrCP1 ubiquitin ligase. Mol. Cell 11, 445-1456 (2003).
67. Skp2 SCF ubiquitin ligase complex. Nature 416, 703-709 (2002). Reports the pivotal three-dimensional structural study of the SCF ligase.
68. Zheng, N., Wang, P., Jeffrey, P. D. & Pavletich, N. P. Structure of a c-Cbl-UbcH7 complex: RlNG domain function in ubiquitin-protein ligases. Cell 102, 533-539 (2000).
69. Huang, L. et al. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 286, 1321-1326 (1999).
70. Verdecia, M. A. et al. Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase. Mol. Cell 11, 249-259 (2003).
71. Cdc4 ubiquitin ligase. Cell 112, 243-256 (2003).
72. Joazeiro, C. A. et al. The tyrosine kinase negative regulator C-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286, 309-312 (1999).
73. Pintard, L. et al. The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. Nature 425, 311-316 (2003).
74. Xu, L. et al. BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature 425, 316-321 (2003).
75. Geyer, R., Wee, S., Andereon, S., Yates, J. & Wolf, D. A. BTB/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases. Mol. Cell 12, 783-790 (2003).
76. Furukawa, M., He, Y. J., Borchers, C. & Xiong, Y. Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nature Cell Biol. 5, 1001-1007 (2003).
77. Hart, M. et al. The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell. Curr. Biol. 9, 207-210 (1999).
78. Kitagawa, M. et al. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of β-catenin. EMBO J. 18, 2401-2410 (1999).
79. Latres, E., Chiaur, D. S. & Pagano, M. The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin. Oncogene 18, 849-854 (1999).
80. β-TRCP ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev. 13, 270-283 (1999).
81. Petroski, M. D. & Deshaies, R. J. Context of multiubiquitin chain attachment influences the rate of Sci1 degradation. Mol. Cell 11, 1435-1444 (2003). Provides a detailed structure-function analysis of Sci1 degradation by an SCF.
82. Klein, R, Pawson, T. & Tyers, M. Mathematical modeling suggests cooperative interactions between a disordered polyvalent ligand and a single receptor site. Curr. Biol. 13, 1669-1678 (2003).
83. Lanker, S., Valdivieso, M. & Wittenberg, C. Rapid degradation of the G1 cyclin Cln2 induced by Cdk-dependent phosphorylation. Science 271, 1597-1601 (1996).
84. Hsiung, Y. G. et al. F-box protein Grr1 interacts with phosphorylated targets via the cationic surface of its leucine-rich repeat. Mol. Cell. Biol. 21, 2506-2520 (2001).
85. Kip1. Mol. Cell 7, 639-650 (2001).
86. Skp2-mediated ubiquitylation of p27. Nature Cell Biol. 3, 321-324 (2001).
87. Seeliger, M. A., Breward, S. E., Friedler, A., Schon, 0. & Itzhaki, L. S. Cooperative organization in a macromolecular complex. Nature Struct. Biol. 10, 718-724 (2003).
88. Kip1. J. Biol. Chem. 278, 32390-32396 (2003).
89. Xu, K. et al. Protein-protein interactions involved in the recognition of p27 by E3 ubiquitin ligase. Biochem. J. 371, 957-964 (2003).
90. Kip1. Biochemistry 41, 752-759 (2002).
91. Waf1/Cip1/Sd1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc. Natl Acad. Sci. USA 93, 11504-11509 (1996).
92. Kip2. Proteins 46, 1-7 (2002).
93. Lacy, E. R. et al. p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding. Nature Struct. Mol. Biol. 11, 358-364 (2004).
94. Sitry, D. et al. Three different binding sites of Cks1 are required for p27-ubiquitin ligation. J. Biol. Chem. 277, 42233-42240 (2002).
95. Bourne, Y. et al. Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1. Cell 84, 863-874 (1996).
96. Russo, A. A., Jeffrey, P. D., Patten, A. K., Massague, J. & Pavletich, N. P. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382, 325-331 (1996). Provides the most complete set of structural data on p27.
97. Mizushima, T. et al. Structural basis of sugar-recognizing ubiquitin ligase. Nature Struct. Mol. Biol. 11, 365-370 (2004).
98. Bloom, J., Amador, V., Bartolini, F., DeMartino, G. & Pagano, M. Proteasome-mediated degradation of p21 via N-terminal ubiquitylation. Cell 115, 71-82 (2003).
99. Suzuki, H. et al. IκBα ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/WD40-repeat proteins, βTrCP1 and βTrCP2. Biochem. Biophys. Res. Commun. 256,127-132 (1999).
100. Cdc4-bound substrate Sic1. Cell 114, 611-622 (2003).
101. Varelas, X., Ptak, C. & Ellison, M. J. Cdc34 self-association is facilitated by ubiquitin thiolester formation and is required for its catalytic activity. Mol. Cell. Biol. 23, 5388-5400 (2003).
102. Pan, Z. Q., Kentsis, A., Dias, D. C., Yamoah, K. & Wu, K. Nedd8 on cullin: building an expressway to protein destruction. Oncogene 23, 1985-1997 (2004).
103. Kus, B. M., Caldon, C. E., Andorn-Broza, R. & Edwards. A. M. Functional interaction of 13 yeast SCF complexes with a set of yeast E2 enzymes in vitro. Proteins 54, 455-467 (2004).
104. Zhou, P. & Howley, P. M. Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligases. Mol. Cell 2, 571-580 (1998).
105. Wirbelauer, C. et al. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts. EMBO J. 19, 5362-5375 (2000).
106. Li, Y., Gazdoiu, S., Pan, Z. Q. & Fuchs, S. Y. Stability of homologue of slimb F-box protein is regulated by availability of its substrate. J. Biol. Chem. 279, 11074-11080 (2004).
107. Pagano, M. & Benmaamar, R. When protein destruction runs amok, malignancy is on the loose. Cancer Cell 4, 251-256 (2003).
108. Bashir, T. & Pagano, M. Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis. Adv. Cancer Res. 88, 101-144 (2003).
109. Pickart, C. M. Back to the future with ubiquitin. Cell 116, 181-190 (2004).
110. Hershko, A., Ciechanover, A. & Varshavsky, A. Basic Medical Research Award. The ubiquitin system. Nature Med. 6, 1073-1081 (2000).
111. Pickart, C. M. & Cohen, R. E. Proteasomes and their kin: proteases in the machine age. Nature Rev. Mol. Cell Biol. 5, 177-187 (2004).
112. Liu, Y. C. Ubiquitin ligases and the immune response. Annu. Rev. Immunol. 22, 81-127 (2004).
113. Kipreos, E. T. & Pagano, M. The F-box protein family. Genome Biol. 1, REVIEWS3002 (2000).
114. Nayak, S. et al. The Caenorhabditis elegans Skp1-related gene family: diverse functions in cell proliferation, morphogenesis, and meiosis. Curr. Biol. 12, 277-287 (2002).
115. Yamanaka, A. et al. Multiple Skp1-related proteins in Caenorhabditis elegans: diverse patterns of interaction with Cullins and F-box proteins. Curr. Biol. 12, 267-275 (2002).
116. Harmon, F. G. & Kay. S. A. The F box protein AFR is a positive regulator of phytochrome A-mediated light signaling. Curr. Biol. 13, 2091-2096 (2003).
117. Marrocco, K., Lecureuil, A., Nicolas, P. & Guerche, P. The Arabidopsis SKP1-like genes present a spectrum of expression profiles. Plant Mol. Biol. 52, 715-727 (2003).
118. Risseeuw, E. P. et al. Protein interaction analysis of SCF ubiquitin E3 ligase subunits from Arabidopsis. Plant J. 34, 753-767 (2003).
119. Owellen, R. J., Hartke. C. A., Dickerson, R. M. & Hans, F O. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class. Cancer Res. 36, 1499-1502 (1976).
120. Baba, M. et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl Acad. Sci. USA 96, 5698-5703 (1999).
121. Arkin, M. R. et al. Binding of small molecules to an adaptive protein-protein interface. Proc. Natl Acad. Sci. USA 100, 1603-1608 (2003).
122. Berg, T. et al. Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc. Natl Acad. Sci. USA 99, 3830-3835 (2002).
123. Chen, J. K., Taipale, J., Young, K. E., Maiti, T. & Beachy, P. A. Small molecule modulation of Smoothened activity. Proc. Natl Acad. Sci. USA 99, 14071-14076 (2002).
124. Lepourcelet, M. et al. Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex. Cancer Cell 5, 91-102 (2004).
125. Vassilev, L. T. et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844-848 (2004). This break-through drug-discovery work established that protein interfaces can be disrupted by small molecules, and that ubiquitin ligases can be targeted.
126. Toogood, P. L. Inhibition of protein-protein association by small molecules: approaches and progress. J. Med. Chem. 45, 1543-1558 (2002).
127. Cochran, A. G. Protein-protein interfaces: mimics and inhibitors. Curr. Opin. Chem. Biol. 5, 654-659 (2001).
128. Mayer, B. J. & Baltimore, D. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell. Biol. 14, 2883-2894 (1994).